Onset and Maintenance of Efficacy of Subcutaneous Tanezumab in Patients With Moderate to Severe Osteoarthritis of the Knee or Hip

Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.122

Related search